APA

Rutanen J., Turunen A., Teittinen M., Rissanen T. T., Heikura T., Koponen J. K., Gruchala M., Inkala M., Jauhiainen S., Hiltunen M. O., Turunen M. P., Stacker S. A., Achen M. G. & Ylä-Herttuala S. (20050920). Gene transfer using the mature form of VEGF-D reduces neointimal thickening through nitric oxide-dependent mechanism. : Gene therapy.

Chicago

Rutanen J, Turunen A-M, Teittinen M, Rissanen T T, Heikura T, Koponen J K, Gruchala M, Inkala M, Jauhiainen S, Hiltunen M O, Turunen M P, Stacker S A, Achen M G and Ylä-Herttuala S. 20050920. Gene transfer using the mature form of VEGF-D reduces neointimal thickening through nitric oxide-dependent mechanism. : Gene therapy.

Harvard

Rutanen J., Turunen A., Teittinen M., Rissanen T. T., Heikura T., Koponen J. K., Gruchala M., Inkala M., Jauhiainen S., Hiltunen M. O., Turunen M. P., Stacker S. A., Achen M. G. and Ylä-Herttuala S. (20050920). Gene transfer using the mature form of VEGF-D reduces neointimal thickening through nitric oxide-dependent mechanism. : Gene therapy.

MLA

Rutanen J, Turunen A-M, Teittinen M, Rissanen T T, Heikura T, Koponen J K, Gruchala M, Inkala M, Jauhiainen S, Hiltunen M O, Turunen M P, Stacker S A, Achen M G and Ylä-Herttuala S. Gene transfer using the mature form of VEGF-D reduces neointimal thickening through nitric oxide-dependent mechanism. : Gene therapy. 20050920.